Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

GSK holding history

GSK plc in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
10,985
Value
$575.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,985$575.8K<0.1%+1,561+16.6%AddedHolders
Q1 20269,424$520.1K<0.1%+1,405+17.5%AddedHolders
Q4 20258,019$393.3K<0.1%+70+0.9%AddedHolders
Q3 20257,949$343.1K<0.1%−1,146−12.6%ReducedHolders
Q2 20259,095$349.2K<0.1%+1,718+23.3%AddedHolders
Q1 20257,377$285.8K<0.1%−2,463−25.0%ReducedHolders
Q4 20249,840$332.8K<0.1%+1,690+20.7%AddedHolders
Q3 20248,150$333.2K<0.1%+1,061+15.0%AddedHolders
Q2 20247,089$272.9K<0.1%−348−4.7%ReducedHolders
Q1 20247,437$318.8K<0.1%+1,207+19.4%AddedHolders
Q4 20236,230$230.9K<0.1%−954−13.3%ReducedHolders
Q3 20237,184$260.4K<0.1%+793+12.4%AddedHolders
Q2 20236,391$227.8K<0.1%+1,802+39.3%AddedHolders
Q1 20234,589$163.3K<0.1%+242+5.6%AddedHolders
Q4 20224,347$152.8K<0.1%+10+0.2%AddedHolders
Q3 20224,337$128.0K<0.1%−1,251−22.4%ReducedHolders
Q2 20225,588$243.0K<0.1%+1,142+25.7%AddedHolders
Q1 20224,446$194.0K<0.1%−2,043−31.5%ReducedHolders
Q4 20216,489$286.0K<0.1%+1,381+27.0%AddedHolders
Q3 20215,108$195.0K<0.1%+664+14.9%AddedHolders
Q2 20214,444$177.0K<0.1%+1,236+38.5%AddedHolders
Q1 20213,208$114.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.